These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 26460209

  • 1. Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation.
    Radivoyevitch T, Sachs RK, Gale RP, Molenaar RJ, Brenner DJ, Hill BT, Kalaycio ME, Carraway HE, Mukherjee S, Sekeres MA, Maciejewski JP.
    Leukemia; 2016 Feb; 30(2):285-94. PubMed ID: 26460209
    [Abstract] [Full Text] [Related]

  • 2. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
    Kaplan H, Malmgren J, De Roos AJ.
    Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
    [Abstract] [Full Text] [Related]

  • 3. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.
    Kaplan HG, Malmgren JA, Atwood MK.
    BMC Cancer; 2011 Jun 21; 11():260. PubMed ID: 21693006
    [Abstract] [Full Text] [Related]

  • 4. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
    Wang R, Zeidan AM, Yu JB, Soulos PR, Davidoff AJ, Gore SD, Huntington SF, Gross CP, Ma X.
    Prostate; 2017 Apr 21; 77(5):437-445. PubMed ID: 27868212
    [Abstract] [Full Text] [Related]

  • 5. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors.
    Kaplan HG, Malmgren JA, Li CI, Calip GS.
    Breast Cancer Res Treat; 2013 Dec 21; 142(3):629-36. PubMed ID: 24265034
    [Abstract] [Full Text] [Related]

  • 6. Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.
    Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, Hamilton BK, Kalaycio M, Maciejewski JP, Ahmed I, Akpek G, Bajel A, Buchbinder D, Cahn JY, D'Souza A, Daly A, DeFilipp Z, Ganguly S, Hamadani M, Hayashi RJ, Hematti P, Inamoto Y, Khera N, Kindwall-Keller T, Landau H, Lazarus H, Majhail NS, Marks DI, Olsson RF, Seo S, Steinberg A, William BM, Wirk B, Yared JA, Aljurf M, Abidi MH, Allewelt H, Beitinjaneh A, Cook R, Cornell RF, Fay JW, Hale G, Chakrabarty JH, Jodele S, Kasow KA, Mahindra A, Malone AK, Popat U, Rizzo JD, Schouten HC, Warwick AB, Wood WA, Sekeres MA, Litzow MR, Gale RP, Hashmi SK.
    Leuk Res; 2018 Nov 21; 74():130-136. PubMed ID: 30055822
    [Abstract] [Full Text] [Related]

  • 7. Therapy-related myelodysplasia and acute myeloid leukemia.
    Bhatia S.
    Semin Oncol; 2013 Dec 21; 40(6):666-75. PubMed ID: 24331189
    [Abstract] [Full Text] [Related]

  • 8. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).
    Freedman RA, Seisler DK, Foster JC, Sloan JA, Lafky JM, Kimmick GG, Hurria A, Cohen HJ, Winer EP, Hudis CA, Partridge AH, Carey LA, Jatoi A, Klepin HD, Citron M, Berry DA, Shulman LN, Buzdar AU, Suman VJ, Muss HB.
    Breast Cancer Res Treat; 2017 Jan 21; 161(2):363-373. PubMed ID: 27866278
    [Abstract] [Full Text] [Related]

  • 9. Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.
    Aguilera DG, Vaklavas C, Tsimberidou AM, Wen S, Medeiros LJ, Corey SJ.
    J Pediatr Hematol Oncol; 2009 Nov 21; 31(11):803-11. PubMed ID: 19801947
    [Abstract] [Full Text] [Related]

  • 10. Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms.
    Nardi V, Winkfield KM, Ok CY, Niemierko A, Kluk MJ, Attar EC, Garcia-Manero G, Wang SA, Hasserjian RP.
    J Clin Oncol; 2012 Jul 01; 30(19):2340-7. PubMed ID: 22585703
    [Abstract] [Full Text] [Related]

  • 11. Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia.
    Klimek VM.
    Curr Opin Hematol; 2013 Mar 01; 20(2):137-43. PubMed ID: 23343830
    [Abstract] [Full Text] [Related]

  • 12. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
    Josting A, Wiedenmann S, Franklin J, May M, Sieber M, Wolf J, Engert A, Diehl V, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2003 Sep 15; 21(18):3440-6. PubMed ID: 12668650
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acute myeloid leukemia and myelodysplastic syndrome following breast cancer: increased frequency of other cancers and of cancers in multiple family members.
    Padmanabhan A, Baker JA, Zirpoli G, Sait SN, Ford LA, Moysich KB, Baer MR.
    Leuk Res; 2008 Dec 15; 32(12):1820-3. PubMed ID: 18468682
    [Abstract] [Full Text] [Related]

  • 15. Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014.
    Teepen JC, Curtis RE, Dores GM, Berrington de Gonzalez A, van den Heuvel-Eibrink MM, Kremer LCM, Gilbert ES, van Leeuwen FE, Ronckers CM, Morton LM.
    Leukemia; 2018 Dec 15; 32(12):2580-2589. PubMed ID: 29795414
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience.
    Smith RE, Bryant J, DeCillis A, Anderson S, National Surgical Adjuvant Breast and Bowel Project Experience.
    J Clin Oncol; 2003 Apr 01; 21(7):1195-204. PubMed ID: 12663705
    [Abstract] [Full Text] [Related]

  • 19. Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study.
    Joelsson J, Wästerlid T, Rosenquist R, Jakobsen LH, El-Galaly TC, Smedby KE, Eloranta S.
    Blood Adv; 2022 Apr 26; 6(8):2657-2666. PubMed ID: 35042239
    [Abstract] [Full Text] [Related]

  • 20. The incidence of secondary leukemias.
    Leone G, Mele L, Pulsoni A, Equitani F, Pagano L.
    Haematologica; 1999 Oct 26; 84(10):937-45. PubMed ID: 10509043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.